(1 - 6 von 7
)
Stammzellen machen Leberschäden reversibel – Innovations Report
www.innovations-report.de
... die nicht behandelt wurden, zeigten keine Veränderung ihres Zustandes. Inder Verma und Yoshiyuki Kanazawa vom Salk Institute for Biological Studies erklärten gegenüber NewScientist, dass eine von ihnen bereits durchgeführte Studie kaum Hinweise auf ein geheiltes Lebergewebe ergeben habe.
NCI (VIET NAM) LIMITED LIABILITY COMPANY
vietnambis.com
Representative: YOSHIYUKI KANAZAWA. Date of license： Start date of activity： Last updated at： Note: The above ...
Experimental Stem Cell Therapy for Cirrhosis | Hepatitis Central
www.hepatitiscentral.com
Further question marks arise from an almost identical study published last year in Proceedings of the National Academy of Sciences (vol 100, p ) by Inder Verma and Yoshiyuki Kanazawa of the Salk Institute for Biological Studies in La Jolla, California, US. They found hardly any evidence of healed ...
Companies tepid on new foreign worker system in Japan - The inklwww.inkl.com › news › companies-tepid-on-new-fo...
www.inkl.com
· ... with better conditions, the expenditures we've made will be for nothing," said Yoshiyuki Kanazawa, an executive of the company.
Liver damage trials break new ground | New Scientist
www.newscientist.com
Bone marrow cells transplanted into mice migrated to repair liver damage – could they do the same for people?
sortiert nach Relevanz / Datum